84 related articles for article (PubMed ID: 12745110)
1. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris.
Chou ET; Schulman SP; Thiemann DR; Sohn RH; Bellantoni MF; Rade JJ
Am J Cardiol; 2003 May; 91(10):1240-2. PubMed ID: 12745110
[No Abstract] [Full Text] [Related]
2. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
Koh KK; Bui MN; Mincemoyer R; Cannon RO
Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
4. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina.
Ghaisas NK; Shahi CN; Foley B; Goggins M; Crean P; Kelly A; Kelleher D; Walsh M
Am J Cardiol; 1997 Sep; 80(5):617-9. PubMed ID: 9294992
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
[TBL] [Abstract][Full Text] [Related]
7. Estrogen, progesterone, and cardiovascular health: when shall we complete the puzzle?
Brzezinski A; Danenberg HD
Menopause; 2005; 12(5):488-91. PubMed ID: 16145300
[No Abstract] [Full Text] [Related]
8. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.
Koh KK; Jin DK; Yang SH; Lee SK; Hwang HY; Kang MH; Kim W; Kim DS; Choi IS; Shin EK
Circulation; 2001 Apr; 103(15):1961-6. PubMed ID: 11306524
[TBL] [Abstract][Full Text] [Related]
9. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules.
Mulvihill NT; Foley JB; Murphy RT; Curtin R; Crean PA; Walsh M
Heart; 2001 Jun; 85(6):623-7. PubMed ID: 11359739
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
Ruszkowska B; Sokup A; Kulwas A; Kwapisz J; Góralczyk K; Socha MW; Rhone P; Rość D
Acta Obstet Gynecol Scand; 2013 Jul; 92(7):841-6. PubMed ID: 23472599
[TBL] [Abstract][Full Text] [Related]
12. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
Lamon-Fava S; Posfai B; Schaefer EJ
Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
[No Abstract] [Full Text] [Related]
13. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
[TBL] [Abstract][Full Text] [Related]
14. Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.
Boehme MW; Gao IK; Norden C; Lemmel EM
Rheumatol Int; 2006 Feb; 26(4):340-7. PubMed ID: 15700117
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
Vitale C; Cornoldi A; Gebara O; Silvestri A; Wajngarten M; Cerquetani E; Fini M; Ramires JA; Rosano GM
Menopause; 2005; 12(5):552-8. PubMed ID: 16145309
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.
Bajaj HS; Ye C; Hanley AJ; Sermer M; Zinman B; Retnakaran R
Diab Vasc Dis Res; 2018 Sep; 15(5):449-457. PubMed ID: 29871496
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, coronary artery disease, and hormones.
Lobo RA
Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
[No Abstract] [Full Text] [Related]
18. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediators.
Cardillo C; Mettimano M; Mores N; Koh KK; Campia U; Panza JA
Vasc Med; 2004 May; 9(3):185-8. PubMed ID: 15675182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
